Kerry Group PLC Kerry announces intent to acquire Biosearch Life (0878P)
February 15 2021 - 3:13AM
UK Regulatory
TIDMKYGA
RNS Number : 0878P
Kerry Group PLC
15 February 2021
15 February 2021
LEI: 635400TLVVBNXLFHWC59
KERRY GROUP
Kerry Group plc announces its intention to acquire Biosearch
Life
Dublin, IRELAND: Kerry Group plc has announced its intention to
acquire the Spanish company Biosearch Life.
Based in Granada, Spain and employing over 150 employees,
Biosearch Life is a leader in the nutraceutical and functional food
sectors. The company has an extensive range of probiotics and is a
recognised leader in premium probiotics obtained from human breast
milk (Hereditum (R) brand), scientifically backed innovative
botanical extracts (Exxentia (R) ) and natural omega-3 (Eupoly-3
(R) brand).
The acquisition is envisaged to be completed by means of a
friendly public tender offer for the shares of Biosearch Life
addressed to all of its shareholders and is subject to the prior
approval of the Spanish National Securities Markets Commission and,
upon its approval, to the acceptance of the offer by Biosearch
Life's shareholders. Grupo Lactalis Iberia, S.A., main shareholder
of Biosearch Life, has irrevocably undertaken to tender its entire
stake representing 29.5% of the share capital of the company into
the offer.
For further details on the terms and conditions of the offer
please see the offer announcement published on the following link:
verDoc.axd (cnmv.es)
ENDS
CONTACT INFORMATION
=============================================
Media
Catherine Keogh , VP Corporate Affairs
& Communications
+353 45 930188 | corpaffairs@kerry.com
Investor Relations
Marguerite Larkin , Chief Financial
Officer
+353 66 7182292 | investorrelations@kerry.ie
William Lynch , Head of Investor
Relations
+353 66 7182292 | investorrelations@kerry.ie
Website
www.kerrygroup.com
About Kerry
Kerry, the Taste & Nutrition company, offers solutions that
nourish lives all over the world. From humble beginnings as an
Irish dairy co-operative, Kerry has grown into a large
international food industry leader, with offices in 32 countries,
149 manufacturing facilities and more than 26,000 employees
globally, including over 1,000 food scientists. It brings to the
table a strong food heritage, coupled with over 40 years of
experience, global insights and market knowledge, culinary and
applications expertise, as well as a range of unique solutions that
anticipate and address customers' needs. For more information,
visit kerrygroup.com .
About Biosearch Life
Biosearch Life is a biotechnology company focused on providing
innovative solutions worldwide in the pharmaceutical, nutraceutical
and functional food sectors providing a wide range of high-quality
products and services which revolve around the concept of a healthy
life. The company has a range of products in three primary areas:
probiotics, omega-3 fatty acids and botanical extracts. Biosearch
Life distributes its products across Europe, Asia and the USA and
has an average annual workforce of over 150 employees.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQSFSSAIEFSEFE
(END) Dow Jones Newswires
February 15, 2021 03:13 ET (08:13 GMT)
Kerry (LSE:KYGA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Kerry (LSE:KYGA)
Historical Stock Chart
From Jan 2024 to Jan 2025